IGF1 and graft versus host disease: Expansion of mature CD16+ NK in this population seemed to correlate with clinical outcomes such as acute GVHD and survival one year after transplant: recently, a model of NK expansion after UCB transplantation after TGF-β and IGF-1 [44] was reported, and the increase in CD16 cells after transplantation should be further explored.